2011
DOI: 10.1016/j.ijpharm.2011.08.044
|View full text |Cite
|
Sign up to set email alerts
|

In-line monitoring and interpretation of an indomethacin anti-solvent crystallization process by near-infrared spectroscopy (NIRS)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
6
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(8 citation statements)
references
References 19 publications
2
6
0
Order By: Relevance
“…Previous reports suggested that the IM crystal form, showing a peak at 161 • C, was the γ form, and that the IM crystal form showing a peak at 155 • C was the α form [27,28]. The DSC results were also consistent with the results of the XRPD spectrum and the morphological features [29]. Previous reports suggested that the IM crystal form, showing a peak at 161°C, was the γ form, and that the IM crystal form showing a peak at 155°C was the α form [27,28].…”
Section: Characterization Of Microparticlessupporting
confidence: 87%
See 1 more Smart Citation
“…Previous reports suggested that the IM crystal form, showing a peak at 161 • C, was the γ form, and that the IM crystal form showing a peak at 155 • C was the α form [27,28]. The DSC results were also consistent with the results of the XRPD spectrum and the morphological features [29]. Previous reports suggested that the IM crystal form, showing a peak at 161°C, was the γ form, and that the IM crystal form showing a peak at 155°C was the α form [27,28].…”
Section: Characterization Of Microparticlessupporting
confidence: 87%
“…Previous reports suggested that the IM crystal form, showing a peak at 161°C, was the γ form, and that the IM crystal form showing a peak at 155°C was the α form [27,28]. The DSC results were also consistent with the results of the XRPD spectrum and the morphological features [29]. From the SEM images of IM-NK(50), IM-KP(50), IM-NK(Dry), and IM-KP(Dry) (Figure 4c-f), it was assumed that the IM crystals as IM microparticles without PVA were coated and bound by PVA.…”
Section: Characterization Of Microparticlessupporting
confidence: 87%
“…Its amorphous form can be conveniently achieved via melting crystallization or crystallization in the presence of an inhibitor (Figure ). For instance, its amorphous form was obtainable in the presence of a comparable amount of a nonionic polymeric additive, poly­(vinylpyrrolidone) (PVP; Figure ), via a solvent evaporation procedure . As expected, increasing the INN/polymer ratio could switch the amorphous INN to crystallize guided by the polymeric additive used, where the polymer-controlled crystallization ensures the appearance of amorphous precursors and elongates their lifetime for the time-resolved detection.…”
Section: Introductionmentioning
confidence: 79%
“…Lee monitored the antisolvent crystallisation process of indomethacin (IMC) by mixing two liquids (IMC-acetone solution and antisolvent water) in two different orders by instantaneously adding the whole IMC-acetone solution into water (H 2 O/IMC solution system) and by rapidly adding water into the IMC-acetone solution (IMC solution/H 2 O system), employing in-line NIR spectroscopy [32]. Accordingly, the metastable a-form with high purity was produced under the H 2 O/IMC solution system, whereas a powder mixture of the stable c-form and the metastable a-form was obtained in the IMC solution/H 2 O system.…”
Section: Glycine Polymorphism By the Rapid Addition Of Methanol Or Samentioning
confidence: 99%